Efficacy and Tolerance Study of B-DYN Versus Conventional Fusion in the Treatment of Lumbar Stenosis on the Degree of Post-operative Functional Incapacity (BDYNCLIN)

Recruiting N/A Interventional Study
Degenerative Lumbar Spinal Stenosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
216 (estimated)
Sponsor
Quanta Medical · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Degenerative Lumbar Spinal Stenosis (LSS) is an extremely common condition affecting more than 102 million people each year. It is a narrowing of the spinal canal in the lower back. It causes pain and even disorders of the lower limbs. When the symptoms get worse and the individual feels functional discomfort despite medical treatment, surgical intervention is recommended. Two surgical options are…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Disease related criteria: 1. Stenosis on 1, 2 or 3 disc levels (grade B or C or D according to Schizas classification or central stenosis of grade A according to Schizas classification with a lateral stenosis (postero-lateral overhang or disc protrusion)) on MRI (lumbar spine M…
Contacts

Vincent POINTILLART, Professor

+33 (0) 1 47 08 63 41

b.hill@quanta-medical.com

CONTACT

Bertrand DEBONO, Doctor

+33 (0) 1 47 08 63 41

b.hill@quanta-medical.com

CONTACT